Viewing Study NCT02588092


Ignite Creation Date: 2025-12-24 @ 3:26 PM
Ignite Modification Date: 2026-02-20 @ 1:44 PM
Study NCT ID: NCT02588092
Status: TERMINATED
Last Update Posted: 2020-02-26
First Post: 2015-08-13
Is Gene Therapy: True
Has Adverse Events: True

Brief Title: Study of ADCT-301 in Patients With Relapsed/Refractory CD25-positive Acute Myeloid Leukemia (AML) or CD25-positive Acute Lymphoblastic Leukemia (ALL)
Sponsor: ADC Therapeutics S.A.
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Acute Myeloid Leukemia View
None Acute Lymphoblastic Leukemia View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Camidanlumab tesirine View